Interleukin 33
From Wikipedia, the free encyclopedia
Interleukin 33
|
|
Identifiers | |
Symbol(s) | IL33 , C9ORF26, IL1F11, NFHEV |
Entrez | 90865 |
OMIM | 608678 |
RefSeq | NM_033439 |
UniProt | O95760 |
Other data | |
Locus | Chr. 9 p24.1 |
Interleukin 33 (IL-33) is a newly discovered cytokine that is structurally related to IL-1 and induces type 2 cytokine production from helper T cells. This cytokine was previously called NF-HEV because it appeared to have a role as a nuclear factor (NF) in high endothelial venules (HEVs).[1] IL-33 mediates its biological effects by interacting with the orphan IL-1 receptor, ST2, activating intracellular molecules in the NF-κB and MAP kinase signaling pathways, that drive production of type 2 cytokines (e.g. IL-4, IL-5 and IL-13) from polarized Th2 cells. The induction of these type 2 cytokines by IL-33 in vivo is attributed to severe pathological changes observed in mucosal organs.[2]
[edit] References
- ^ E.S. Baekkevold et al., Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. American Journal of Patholology, 2003, Volume 163, pages 69-79.
- ^ J. Schmitz et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 2005 Volume 23, pages 479-90.